Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1419

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 12
Chunk 1419
---
 Form S-1 filed July 28, 2023).
  
    10.4
     
    Confirmatory
    Patent Assignment and Royalty Agreement, dated November 1, 2021, between SRQ Patent Holdings II, LLC and MIRA Pharmaceuticals, Inc.
    (incorporated by reference to Exhibit 10.4 to Form S-1 filed July 28, 2023).
  
    10.5
     
    Amended
    and Restated Limited License Agreement, dated June 27, 2022, between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals, Inc. (incorporated
    by reference to Exhibit 10.5 to Form S-1 filed July 28, 2023).
  
    10.6
     
    Amendment
    No. 1, dated April 20, 2023, to Amended and Restated Limited License Agreement between MIRA Pharmaceuticals, Inc. and MyMD Pharmaceuticals,
    Inc. (incorporated by reference to Exhibit 10.6 to Form S-1 filed July 28, 2023).
  
    10.7+
     
    Employment Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (incorporated by reference to Exhibit 10.7 to Form S-1 filed July 28, 2023).
  
    10.8+
     
    Amendment
    to Employment Agreement, August 28, 2023, between MIRA Pharmaceuticals, Inc. and Erez Aminov (incorporated by reference to Exhibit
    10.1 to the Current Report on Form 8-K filed August 31, 2023).
  
    10.9+
     
    Employment
    Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Michelle Yanez (incorporated by reference to Exhibit 10.8
    to Form S-1 filed July 28, 2023).
  
    10.10
     
    Promissory
    Note and Loan Agreement, dated April 28, 2023, between MIRA Pharmaceuticals, Inc. and Bay Shore Trust (incorporated by reference
    to Exhibit 10.10 to Form S-1 filed July 28, 2023).
  
    10.11
     
    Registration
    Rights Agreement